Low-Grade Serous Ovarian Cancer — Trials

Low-Grade Serous Ovarian Cancer — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 60%
Top sponsor: Verastem, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03875820	Phase I Trial of Defactinib and VS-6766.(FRAME)	active not recruiting	Phase 1	87	Institute of Cancer Research, United KingdomOTHER	1	Mar 10, 2026	clinicaltrials
NCT06682572	A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients(RAMP201J)	active not recruiting	Phase 2	16	Verastem, Inc.INDUSTRY	1	Dec 17, 2025